Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion
Identifieur interne : 003319 ( Pmc/Corpus ); précédent : 003318; suivant : 003320Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion
Auteurs : Ane Gerda Zahl Eriksson ; Jen Ducie ; Narisha Ali ; Michaela E. Mcgree ; Amy L. Weaver ; Giorgio Bogani ; William A. Cliby ; Sean C. Dowdy ; Jamie N. Bakkum-Gamez ; Nadeem R. Abu-Rustum ; Andrea Mariani ; Mario M. LeitaoSource :
- Gynecologic oncology [ 0090-8258 ] ; 2015.
Abstract
To assess clinicopathologic outcomes between two nodal assessment approaches in patients with endometrioid endometrial carcinoma and limited myoinvasion.
Patients with endometrial cancer at two institutions were reviewed. At one institution, a complete pelvic and para-aortic lymphadenectomy to the renal veins was performed in select cases deemed at risk for nodal metastasis due to grade 3 cancer and/or primary tumor diameter >2 cm (LND cohort). This is a historic approach at this institution. At the other institution, a sentinel lymph node mapping algorithm was used per institutional protocol (SLN cohort). Low risk was defined as endometrioid adenocarcinoma with myometrial invasion <50%. Macrometastasis, micrometastasis, and isolated tumor cells were all considered node-positive.
Of 1135 cases identified, 642 (57%) were managed with an SLN approach and 493 (43%) with an LND approach. Pelvic nodes (PLNs) were removed in 93% and 58% of patients, respectively (P<0.001); para-aortic nodes (PANs) were removed in 14.5% and 50% of patients, respectively (P<0.001). Median number of PLNs removed was 6 and 34, respectively; median number of PANs removed was 5 and 16, respectively (both P<0.001). Metastasis to PLNs was detected in 5.1% and 2.6% of patients, respectively (P=0.03), and to PANs in 0.8% and 1.0%, respectively (P=0.75). The 3-year disease-free survival rates were 94.9% (95%CI, 92.4–97.5) and 96.8% (95%CI, 95.2–98.5), respectively.
Our findings support the use of either strategy for endometrial cancer staging, with no apparent detriment to the SLN algorithm. The clinical significance of disease detected on ultrastaging and the role of adjuvant therapy is yet to be determined.
Url:
DOI: 10.1016/j.ygyno.2015.12.028
PubMed: 26747778
PubMed Central: 4839486
Links to Exploration step
PMC:4839486Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion</title>
<author><name sortKey="Eriksson, Ane Gerda Zahl" sort="Eriksson, Ane Gerda Zahl" uniqKey="Eriksson A" first="Ane Gerda Zahl" last="Eriksson">Ane Gerda Zahl Eriksson</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ducie, Jen" sort="Ducie, Jen" uniqKey="Ducie J" first="Jen" last="Ducie">Jen Ducie</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ali, Narisha" sort="Ali, Narisha" uniqKey="Ali N" first="Narisha" last="Ali">Narisha Ali</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mcgree, Michaela E" sort="Mcgree, Michaela E" uniqKey="Mcgree M" first="Michaela E." last="Mcgree">Michaela E. Mcgree</name>
<affiliation><nlm:aff id="A2">Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weaver, Amy L" sort="Weaver, Amy L" uniqKey="Weaver A" first="Amy L." last="Weaver">Amy L. Weaver</name>
<affiliation><nlm:aff id="A2">Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Bogani, Giorgio" sort="Bogani, Giorgio" uniqKey="Bogani G" first="Giorgio" last="Bogani">Giorgio Bogani</name>
<affiliation><nlm:aff id="A3">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cliby, William A" sort="Cliby, William A" uniqKey="Cliby W" first="William A." last="Cliby">William A. Cliby</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Dowdy, Sean C" sort="Dowdy, Sean C" uniqKey="Dowdy S" first="Sean C." last="Dowdy">Sean C. Dowdy</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Bakkum Gamez, Jamie N" sort="Bakkum Gamez, Jamie N" uniqKey="Bakkum Gamez J" first="Jamie N." last="Bakkum-Gamez">Jamie N. Bakkum-Gamez</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Abu Rustum, Nadeem R" sort="Abu Rustum, Nadeem R" uniqKey="Abu Rustum N" first="Nadeem R." last="Abu-Rustum">Nadeem R. Abu-Rustum</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A5">Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mariani, Andrea" sort="Mariani, Andrea" uniqKey="Mariani A" first="Andrea" last="Mariani">Andrea Mariani</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Leitao, Mario M" sort="Leitao, Mario M" uniqKey="Leitao M" first="Mario M." last="Leitao">Mario M. Leitao</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A5">Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26747778</idno>
<idno type="pmc">4839486</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839486</idno>
<idno type="RBID">PMC:4839486</idno>
<idno type="doi">10.1016/j.ygyno.2015.12.028</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">003319</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003319</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion</title>
<author><name sortKey="Eriksson, Ane Gerda Zahl" sort="Eriksson, Ane Gerda Zahl" uniqKey="Eriksson A" first="Ane Gerda Zahl" last="Eriksson">Ane Gerda Zahl Eriksson</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ducie, Jen" sort="Ducie, Jen" uniqKey="Ducie J" first="Jen" last="Ducie">Jen Ducie</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ali, Narisha" sort="Ali, Narisha" uniqKey="Ali N" first="Narisha" last="Ali">Narisha Ali</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mcgree, Michaela E" sort="Mcgree, Michaela E" uniqKey="Mcgree M" first="Michaela E." last="Mcgree">Michaela E. Mcgree</name>
<affiliation><nlm:aff id="A2">Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weaver, Amy L" sort="Weaver, Amy L" uniqKey="Weaver A" first="Amy L." last="Weaver">Amy L. Weaver</name>
<affiliation><nlm:aff id="A2">Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Bogani, Giorgio" sort="Bogani, Giorgio" uniqKey="Bogani G" first="Giorgio" last="Bogani">Giorgio Bogani</name>
<affiliation><nlm:aff id="A3">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cliby, William A" sort="Cliby, William A" uniqKey="Cliby W" first="William A." last="Cliby">William A. Cliby</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Dowdy, Sean C" sort="Dowdy, Sean C" uniqKey="Dowdy S" first="Sean C." last="Dowdy">Sean C. Dowdy</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Bakkum Gamez, Jamie N" sort="Bakkum Gamez, Jamie N" uniqKey="Bakkum Gamez J" first="Jamie N." last="Bakkum-Gamez">Jamie N. Bakkum-Gamez</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Abu Rustum, Nadeem R" sort="Abu Rustum, Nadeem R" uniqKey="Abu Rustum N" first="Nadeem R." last="Abu-Rustum">Nadeem R. Abu-Rustum</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A5">Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mariani, Andrea" sort="Mariani, Andrea" uniqKey="Mariani A" first="Andrea" last="Mariani">Andrea Mariani</name>
<affiliation><nlm:aff id="A4">Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Leitao, Mario M" sort="Leitao, Mario M" uniqKey="Leitao M" first="Mario M." last="Leitao">Mario M. Leitao</name>
<affiliation><nlm:aff id="A1">Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A5">Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Gynecologic oncology</title>
<idno type="ISSN">0090-8258</idno>
<idno type="eISSN">1095-6859</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Objectives</title>
<p id="P1">To assess clinicopathologic outcomes between two nodal assessment approaches in patients with endometrioid endometrial carcinoma and limited myoinvasion.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">Patients with endometrial cancer at two institutions were reviewed. At one institution, a complete pelvic and para-aortic lymphadenectomy to the renal veins was performed in select cases deemed at risk for nodal metastasis due to grade 3 cancer and/or primary tumor diameter >2 cm (LND cohort). This is a historic approach at this institution. At the other institution, a sentinel lymph node mapping algorithm was used per institutional protocol (SLN cohort). Low risk was defined as endometrioid adenocarcinoma with myometrial invasion <50%. Macrometastasis, micrometastasis, and isolated tumor cells were all considered node-positive.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Of 1135 cases identified, 642 (57%) were managed with an SLN approach and 493 (43%) with an LND approach. Pelvic nodes (PLNs) were removed in 93% and 58% of patients, respectively (P<0.001); para-aortic nodes (PANs) were removed in 14.5% and 50% of patients, respectively (P<0.001). Median number of PLNs removed was 6 and 34, respectively; median number of PANs removed was 5 and 16, respectively (both P<0.001). Metastasis to PLNs was detected in 5.1% and 2.6% of patients, respectively (P=0.03), and to PANs in 0.8% and 1.0%, respectively (P=0.75). The 3-year disease-free survival rates were 94.9% (95%CI, 92.4–97.5) and 96.8% (95%CI, 95.2–98.5), respectively.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Our findings support the use of either strategy for endometrial cancer staging, with no apparent detriment to the SLN algorithm. The clinical significance of disease detected on ultrastaging and the role of adjuvant therapy is yet to be determined.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0365304</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3932</journal-id>
<journal-id journal-id-type="nlm-ta">Gynecol Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">Gynecol. Oncol.</journal-id>
<journal-title-group><journal-title>Gynecologic oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0090-8258</issn>
<issn pub-type="epub">1095-6859</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">26747778</article-id>
<article-id pub-id-type="pmc">4839486</article-id>
<article-id pub-id-type="doi">10.1016/j.ygyno.2015.12.028</article-id>
<article-id pub-id-type="manuscript">NIHMS774727</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Eriksson</surname>
<given-names>Ane Gerda Zahl</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ducie</surname>
<given-names>Jen</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ali</surname>
<given-names>Narisha</given-names>
</name>
<degrees>MS, PA-C</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author"><name><surname>McGree</surname>
<given-names>Michaela E.</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Weaver</surname>
<given-names>Amy L.</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Bogani</surname>
<given-names>Giorgio</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Cliby</surname>
<given-names>William A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Dowdy</surname>
<given-names>Sean C.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Bakkum-Gamez</surname>
<given-names>Jamie N.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Abu-Rustum</surname>
<given-names>Nadeem R.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mariani</surname>
<given-names>Andrea</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Leitao</surname>
<given-names>Mario M.</given-names>
<suffix>Jr</suffix>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>
Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
<aff id="A2"><label>b</label>
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA</aff>
<aff id="A3"><label>c</label>
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</aff>
<aff id="A4"><label>d</label>
Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA</aff>
<aff id="A5"><label>e</label>
Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</aff>
<author-notes><corresp id="cor1"><bold>Corresponding Author:</bold>
Mario M. Leitao, Jr., MD, Gynecology Service, Dept of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, Tel: (212) 639-3987, Fax: (212) 366-4436, <email>leitaom@mskcc.org</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>8</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>31</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<volume>140</volume>
<issue>3</issue>
<fpage>394</fpage>
<lpage>399</lpage>
<pmc-comment>elocation-id from pubmed: 10.1016/j.ygyno.2015.12.028</pmc-comment>
<abstract><sec id="S1"><title>Objectives</title>
<p id="P1">To assess clinicopathologic outcomes between two nodal assessment approaches in patients with endometrioid endometrial carcinoma and limited myoinvasion.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">Patients with endometrial cancer at two institutions were reviewed. At one institution, a complete pelvic and para-aortic lymphadenectomy to the renal veins was performed in select cases deemed at risk for nodal metastasis due to grade 3 cancer and/or primary tumor diameter >2 cm (LND cohort). This is a historic approach at this institution. At the other institution, a sentinel lymph node mapping algorithm was used per institutional protocol (SLN cohort). Low risk was defined as endometrioid adenocarcinoma with myometrial invasion <50%. Macrometastasis, micrometastasis, and isolated tumor cells were all considered node-positive.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Of 1135 cases identified, 642 (57%) were managed with an SLN approach and 493 (43%) with an LND approach. Pelvic nodes (PLNs) were removed in 93% and 58% of patients, respectively (P<0.001); para-aortic nodes (PANs) were removed in 14.5% and 50% of patients, respectively (P<0.001). Median number of PLNs removed was 6 and 34, respectively; median number of PANs removed was 5 and 16, respectively (both P<0.001). Metastasis to PLNs was detected in 5.1% and 2.6% of patients, respectively (P=0.03), and to PANs in 0.8% and 1.0%, respectively (P=0.75). The 3-year disease-free survival rates were 94.9% (95%CI, 92.4–97.5) and 96.8% (95%CI, 95.2–98.5), respectively.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Our findings support the use of either strategy for endometrial cancer staging, with no apparent detriment to the SLN algorithm. The clinical significance of disease detected on ultrastaging and the role of adjuvant therapy is yet to be determined.</p>
</sec>
</abstract>
<kwd-group><kwd>Endometrial carcinoma</kwd>
<kwd>sentinel lymph node</kwd>
<kwd>sentinel lymph node algorithm</kwd>
<kwd>SLN algorithm</kwd>
<kwd>comprehensive lymphadenectomy</kwd>
<kwd>ultrastaging</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003319 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 003319 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:4839486 |texte= Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:26747778" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |